OUTCOMES AFTER USING VEDOLIZUMAB IN PAEDIATRIC INFLAMMATORY BOWEL DISEASE IN A TERTIARY CENTRE, OVER A 3 YEAR PERIOD
Subscribe
Login
Please login to comment
0 Comments
